Proteomic signatures reveal early signs of cardiovascular-kidney-metabolic disease in children

https://www.news-medical.net/news/20260911/Proteomic-signatures-reveal-early-signs-of-cardiovascular-kidney-metabolic-disease-in-children.aspx Researchers at Vanderbilt Health, UTHealth Houston and the University of North Carolina at Chapel Hill have identified early signs of cardiovascular-kidney-metabolic disease (CKMD) in children as young as 8 years old that potentially can be reversed with a new class of weight loss drugs used widely by adults. Using cutting-edge analytic techniques, the researchers defined a "signature" of circulating proteins in children and adolescents that mirrored the molecular biomarkers associated with irreversible cardiovascular disease in adults.